Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model

Fig. 2

Hepatitis B surface antibody (anti-HBs) titres mediated by vaccination in the entire cohort and in HIV-positive (HIV+) and HIV-negative (HIV−) children aged 6–60 months in Kimberley, South Africa. A Doughnut charts indicating the proportion of the cohort achieving anti-HBs titres of ≥ 10 mIU/ml or ≥ 100 mIU/ml. B Scatter plot representing vaccine-mediated antibody titres according to HIV-status, indicating median and interquartile ranges (p value by Mann Whitney U test). C Proportion of children with anti-HBs ≥ 10 mIU/ml or ≥ 100 mIU/ml according to HIV-status (p values by Fisher’s exact test)

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us